Ciprofloxacin-SOLOfarm

Indications for use
In ophthalmology: treatment of corneal ulcers and infections of the anterior segment of the eyeball and its appendages caused by bacteria susceptible to ciprofloxacin in adults, newborns (from 0 to 27 days), children in arms and infants (from 28 days to 23 months), children (from 2 up to 11 years old) and teenagers (from 12 to 18 years old).
In otorhinolaryngology: otitis externa, treatment of postoperative infectious complications.
Therapeutic class:
Antimicrobial agent Fluoroquinolone
INN
Ciprofloxacin 0.3%
Market authorization in the following countries
Georgia